文献速递贫血与红细胞疾病

红细胞水合障碍

Disorders of erythrocyte hydration.
PubMed 文献 · Blood · 2017-10-19

红细胞通过多条通路在渗透扰动下调节盐和水含量,以维持窄范围细胞血红蛋白浓度。原发性水合障碍涉及PIEZO1、GLUT1、SLC4A1、RhAG、KCNN4和ABCB6等蛋白的遗传异质性,临床表现多样。继发性水合障碍包括镰状细胞病、地中海贫血、血红蛋白CC和遗传性球形红细胞增多症,细胞脱水可能加重病理和临床并发症。

要点

  • 红细胞水合调控依赖多条通路,维持窄范围细胞血红蛋白浓度对红细胞功能和存活至关重要。
  • 原发性水合障碍具有临床、实验室、生理和遗传异质性,涉及PIEZO1、GLUT1、SLC4A1、RhAG、KCNN4和ABCB6等蛋白。
  • 继发性水合障碍中细胞脱水可能显著促进疾病病理和临床并发症。

核心结论

  • 理解调节红细胞水和溶质含量的通路可能为维持原发或继发性细胞脱水相关疾病中的正常体积提供创新策略,并可能揭示红细胞以外疾病预防和治疗的新靶点。

研究设计与样本

  • 综述,阐述红细胞水合调控通路及原发性和继发性水合障碍的机制与遗传异质性。

主要发现

  • 原发性水合障碍由PIEZO1、GLUT1、SLC4A1、RhAG、KCNN4和ABCB6等蛋白参与维持红细胞体积稳态。
  • 继发性水合障碍包括镰状细胞病、地中海贫血、血红蛋白CC和遗传性球形红细胞增多症,细胞脱水可能显著促进病理和临床并发症。

关键数值与推荐

  • 原发性水合障碍以临床、实验室、生理和遗传异质性为特征。
  • 继发性水合障碍中细胞脱水可能显著促进疾病病理和临床并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The erythrocyte contains a network of pathways that regulate salt and water content in the face of extracellular and intracellular osmotic perturbations. This allows the erythrocyte to maintain a narrow range of cell hemoglobin concentration, a process critical for normal red blood cell function and survival. Primary disorders that perturb volume homeostasis jeopardize the erythrocyte and may lead to its premature destruction. These disorders are marked by clinical, laboratory, and physiologic heterogeneity. Recent studies have revealed that these disorders are also marked by genetic heterogeneity. They have implicated roles for several proteins, PIEZO1, a mammalian mechanosensory protein; GLUT1, the glucose transporter; SLC4A1, the anion transporter; RhAG, the Rh-associated glycoprotein; KCNN4, the Gardos channel; and ABCB6, an adenosine triphosphate-binding cassette family member, in the maintenance of erythrocyte volume homeostasis. Secondary disorders of erythrocyte hydration include sickle cell disease, thalassemia, hemoglobin CC, and hereditary spherocytosis, where cellular dehydration may be a significant contributor to disease pathology and clinical complications. Understanding the pathways regulating erythrocyte water and solute content may reveal innovative strategies to maintain normal volume in disorders associated with primary or secondary cellular dehydration. These mechanisms will serve as a paradigm for other cells and may reveal new therapeutic targets for disease prevention and treatment beyond the erythrocyte.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Gallagher PG. Disorders of erythrocyte hydration. Blood. 2017. PMID: 29051181. doi:10.1182/blood-2017-04-590810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。